CAS: 1018448-65-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Trastuzumab emtansine REF: TM-T36647CAS: 1018448-65-1 | 98% | 1,241.00 €~2,022.00 € | Tue 03 Dec 24 |
 | Trastuzumab emtansine REF: 3D-CLA1033CAS: 1018448-65-1 | - - - | To inquire | Fri 13 Dec 24 |
Trastuzumab emtansine
CAS:1018448-65-1
Trastuzumab emtansine is a HER2-targeted ADC for advanced breast cancer, combining trastuzumab with DM1 cytotoxicity.
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T36647
| 5mg | 1,241.00 € | ||
| 10mg | 2,022.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Trastuzumab emtansine
CAS:1018448-65-1
Antibody-drug conjugate (ADC) of HER2-targeted trastuzumab with cytotoxic microtubule-inhibitory agent DM1 (derivative of maytansine).
Ref: 3D-CLA1033
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 13 Dec 2024
